What should I Know Regarding Pregnancy, Nursing and Administering Avelox IV Solution, Intravenous Piggyback to Children or the Elderly?
If you are PREGNANT
- FDB Only When Necessary: INSUFF HUMAN DATA; ANIMAL DATA SUG DEV TOX AT DOSES <2.5 X MRHD
If you are NURSING
- Precaution: INSUFFICIENT DATA AVAILABLE
If you are an adult over 60
- management or monitoring precaution: Musculoskeletal-Increased risk for tendinitis, tendon rupture particularly with corticosteroid use. Endocrine-Risk for hypoglycemia in diabetes. Cardiovascular-Elderly may be more susceptible to the QT-prolongation. Electrolytes should be corrected (e.g. K, Mg). Increased rate of aortic aneurysm and dissection within two months of use, Neuro/Psych-Risk for peripheral neuropathy which may affect walking and increase fall risk. CNS stimulation may occur (confusion, anxiety, insomnia).
Giving Avelox IV Solution, Intravenous Piggyback to a child under 12
- Severe Precaution: Known risk of tendinitis and tendon rupture, QT prolongation. Joint lesions observed in juvenile animal studies. Safety and efficacy not established in complicated intra-abdominal infection trial.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.